Back to Search
Start Over
Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome
- Source :
- The Journal of Pediatrics
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
-
Abstract
- To compare prenatal exposures, hospital care processes, and hospitalization outcomes for opioid-exposed newborns before and during the coronavirus disease 2019 (COVID-19) pandemic.In this multicenter retrospective analysis, data were collected from 19 Massachusetts hospitals, including 5 academic and 14 community hospitals. The pre-COVID-19 cohort was defined as births occurring during March 1, 2019-February 28, 2020, and the COVID-19 cohort was defined as births occurring during March 1, 2020-December 31, 2020. Opioid-exposed newborns born at ≥35 weeks of gestation were included. Differences in prenatal substance exposures, hospital care processes, and neonatal opioid withdrawal syndrome (NOWS) outcomes, including pharmacologic treatment for NOWS (PharmTx), length of stay (LOS), and as-needed (prn) treatment failure rates, were evaluated.There were 663 opioid-exposed newborns in the pre-COVID-19 group and 476 in the COVID-19 group. No between-group differences were seen in prenatal substance exposures or the need for PharmTx. Compared with the pre-COVID-19 group, in the COVID-19 group there was less rooming-in after maternal discharge (53.8% vs 63.0%; P = .001) and less care in the pediatric unit setting (23.5% vs 25.3%; P = .001), longer LOS (adjusted risk ratio, 1.04; 95% CI, 1.01-1.08), and a higher rate of breast milk receipt at discharge (aOR, 2.03; 95% CI, 1.22-3.39). Within the subset of academic centers, more infants failed prn treatment in the COVID-19 group (53.8% vs 26.5%, P = .02; aOR, 3.77; 95% CI, 0.98-14.5).Among the hospitals in our collaborative, hospital processes for NOWS, including care setting, rooming-in, and LOS were negatively impacted in the COVID-19 group, particularly in academic medical centers.
- Subjects :
- medication for opioid use disorder, MOUD
when necessary, PRN
opioid use disorder, OUD
Coronavirus Disease 2019, COVID-19
Pregnancy
Humans
Child
Retrospective Studies
SARS-CoV-2
Infant, Newborn
Infant
Original Articles
Opioid-Related Disorders
Neonatal Abstinence Syndrome (NAS)
Perinatal-Neonatal Quality Improvement Network of Massachusetts, PNQIN
Hospitals
opioid exposed newborns, OEN
Eat, Sleep, Console, ESC
COVID-19 Drug Treatment
Analgesics, Opioid
Coronavirus
Neonatal Opioid Withdrawal Syndrome, NOWS
Pediatrics, Perinatology and Child Health
pharmacologic treatment for neonatal opioid withdrawal syndrome, PharmTx
Female
length of stay, LOS
Neonatal Abstinence Syndrome
Subjects
Details
- ISSN :
- 00223476
- Volume :
- 245
- Database :
- OpenAIRE
- Journal :
- The Journal of Pediatrics
- Accession number :
- edsair.doi.dedup.....7be8bd4d058eaf0846f57943af3285df